Table 2.
Participant characteristics (N = 219)
| Characteristic (measure) | Group A (n = 55) Mean ± SD or n (%) | Group B (n = 83) Mean ± SD or n (%) | Healthy controls (n = 81) Mean ± SD or n (%) | F or χ2 test statistic p value |
|---|---|---|---|---|
| Age (years) | 58.76 ± 5.47 | 62.47 ± 5.96 | 60.06 ± 6.08 | <.001* |
| Education (years) | 15.67 ± 2.78 | 14.95 ± 3.06 | 14.84 ± 2.91 | .232 |
| Estimated verbal intelligence (NART-R) | 108.94 ± 8.87 | 107.04 ± 8.84 | 114.72 ± 7.84 | <.001* |
| Depression (BDI-II) | 5.24 ± 6.61 | 4.60 ± 4.65 | 4.83 ± 5.52 | .760 |
| Anxiety (POMS tension-anxiety subscale) | 9.61 ± 6.14 | 6.97 ± 4.65 | 6.61 ± 5.63 | .004* |
| Fatigue (POMS fatigue-inertia subscale) | 5.11 ± 5.33 | 5.84 ± 6.35 | 5.74 ± 5.99 | .759 |
| Pain (BPI) | 1.47 ± 1.96 | 1.55 ± 2.27 | 0.94 ± 2.07 | .144 |
| Marital status, married | 38 (69.1) | 54 (65.1) | 46 (56.8) | .306 |
| Number of children | 1.75 ± 1.22 | 2.05 ± 1.39 | 2.12 ± 1.53 | .283 |
| Race, Caucasian | 52 (94.5) | 81 (97.6) | 75 (92.6) | .337 |
| Cancer stage | ||||
| Stage 1 | 25 (45.5) | 69 (83.1) | – | – |
| Stage 2a | 19 (34.5) | 12 (14.5) | – | – |
| Stage 2b | 5 (9.1) | 2 (2.4) | – | – |
| Stage 3a | 6 (10.9) | 0 (0.0) | – | – |
SD, standard deviation; Group A, prescribed chemotherapy plus anastrozole; Group B, prescribed anastrozole alone; NART-R, National Adult Reading Test-Revised; BDI-II, Beck Depression Inventory-II, POMS, Profile of Mood States; BPI, Brief Pain Inventory. One-way ANOVAs utilized to compare study cohort means of continuous variables. Pearson’s Chi square tests of independence used to examine the general associations between categorical variables
* p < .05